Prenazone; Fenilprenazone; Phenylprenazone; Methrazone; Pheprazone; Analud; DA 2370; UNII-7BVX6J0CGR; 4-(3-methylbut-2-en-1-yl)-1,2-diphenylpyrazolidine-3,5-dione; 4-Prenyl-1,2-diphenyl-3,5-dioxopyrazolidine; 4-Prenyl-1,2-diphenyl-3,5-pyrazolidinedione; 7BVX6J0CGR; 3,5-Pyrazolidinedione, 4-(3-methyl-2-butenyl)-1,2-diphenyl-; DA2370; Prenazone;Zepelin; 4-(2-Isopentenyl)-1,2-diphenyl-3,5-pyrazolidinedione; 4-(3-methylbut-2-enyl)-1,2-diphenylpyrazolidine-3,5-dione; 1,2-Diphenyl-4-(3-methyl-2-butenyl)-3,5-pyrazolidinedione; 4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione; NCGC00164582-01; 3,5-PYRAZOLIDINEDIONE, 1,2-DIPHENYL-4-(3-METHYL-2-BUTENYL)-; DSSTox_CID_3051; DSSTox_RID_76853; DSSTox_GSID_23051; Feprazonum; Feprazona; Feprazonum [INN-Latin]; Feprazona [INN-Spanish]; EINECS 250-324-3; DA-2370; BRN 3984862; Feprazone [INN:BAN:JAN]; Feprazone,(S); 4-(beta-Isoamylenyl)-1,2-diphenyl-3,5-pyrazolidinedione; Feprazone (JAN/INN); Oprea1_389577; SCHEMBL24186; CHEMBL1452696; DTXSID3023051; CTK8F9750; 4-(3-methylbut-2-enyl)-1,2-diphenyl-pyrazolidine-3,5-dione; BCP28058; Tox21_112208; BDBM50248306; AKOS015895168; Tox21_112208_1; ZINC100016068; AC-2079; DB13364; NCGC00164582-02; DB-047893; FT-0630555; D01305; 748F299; A820600; Q999936; J-018097; 4-(.beta.-Isoamylenyl)-1,2-diphenyl-3,5-pyrazolidinedione; 4-(3-methyl-2-butenyl)-1,2-diphenyl-3,5-dioxo-pyrazolidine; 4-(3-methyl-2-butenyl)-1,2-diphenyl-3,5-dioxopyrazolidine; 3,5-Pyrazolidinedione, 4-(3-methyl-2-buten-1-yl)-1,2-diphenyl-